The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Gene Expression Market In 2026, And How Will Its Value Evolve By 2030?
The gene expression market size has experienced rapid expansion in recent years. It is anticipated to increase from $12.67 billion in 2025 to $14.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The growth observed in the historical period is attributable to several factors, including increased funding for academic genomics research, the rising prevalence of chronic and genetic diseases, the early adoption of microarray technologies, the expansion of pharmaceutical R&D pipelines, and the growing utilization of PCR-based techniques.
The gene expression market is projected for significant expansion in the coming years, with its size anticipated to reach $22.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This growth throughout the forecast period stems from various factors, including advancements in RNA sequencing technologies, an increasing focus on precision medicine, the proliferation of clinical diagnostics applications, the integration of AI into gene expression data analysis, and expanding investments within the biotechnology industry. Major developments expected during this period include the wider application of single-cell gene expression analysis, a rise in the use of spatial transcriptomics, growing demand for high-throughput PCR platforms, the increasing adoption of multi-omics integration, and the standardization of gene expression workflows.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp
Which Primary Drivers Are Impacting The Gene Expression Market Growth?
The increasing prevalence of chronic diseases is projected to stimulate the expansion of the gene expression market moving forward. Chronic diseases are long-term health conditions that endure for an extended duration, typically three months or more. Gene expression analysis is employed in these conditions to unravel their underlying molecular mechanisms, pinpoint potential biomarkers, and formulate targeted therapeutic strategies. For instance, in June 2024, data from the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition marked by elevated blood sugar levels, not severe enough to be classified as diabetes) in 2023. This marked an 18% increase from 3,065,825 cases in 2022. Thus, the escalation in chronic diseases will propel the growth of the gene expression market.
What Segment Categories Shape The Gene Expression Market Segment Landscape?
The gene expression market covered in this report is segmented –
1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products
2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation
3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis
4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications
Subsegments:
1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents
2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays
3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables
Which Trends Are Guiding The Direction Of The Gene Expression Market?
Leading companies in the gene expression market are concentrating on developing innovative products, such as gene detection assays, to gain a competitive edge and boost revenue. A gene detection assay within gene expression refers to a method for pinpointing and quantifying genetic molecules, offering insights into the activity and abundance of specific genes. For instance, in January 2023, Bio-Techne Corporation, a US-based biotech company specializing in research instruments, expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by launching the RNAscope Plus smRNA-RNA detection assay. This new assay facilitates the simultaneous fluorescent identification of a small regulatory RNA along with three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution. Tailored for large studies, the assay is compatible with the Leica Bond Rx platform and is available as a manual assay for convenient application. These therapeutic nucleic acids hold the potential to modify the expression and functionality of specific target genes, thereby enabling the creation of customized treatments for inherited or acquired diseases that have proven resistant to conventional therapies.
Who Are The Companies Operating Across The Gene Expression Market Value Chain?
Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation
Get The Full Gene Expression Market Report:
https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report
Which Region Leads The Gene Expression Market In Overall Market Size?
North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gene Expression Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report
Browse Through More Reports Similar to the Global Gene Expression Market 2026, By The Business Research Company
Gene Expression Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report
Protein Expression Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model